Tykerb 250 mg Tablets
Available with trade name lapatinib, this Tykerb 250 mg Tablets belongs to the class of signal transduction inhibitor - tyrosine kinase inhibitor and inhibitor of EGFR and HER2. These are effective in combination with other medication (capecitabine) in order to treat breast cancer type of HER2-positive which has not responded to the standard treatment. In addition, they can be also together with letrozole for the treatment of HER2-positive breast cancer in women post menopause. This medicine is highly effective in slowing down and stopping the growth of cancer cells.
Brand Name: Tykerb
Generic Name: Lapatinib
Strength: 250 mg
"We mainly deliver our products to the foreign countries."